ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

Safer CRISPR? Cas13 version edits RNA, not DNA – Genetic Literacy Project

Continue reading

2017-11-01 Michael Zand NEWS

Collaboration to Develop Gene Therapies Delivery – Labmate Online


Genetic Literacy Project

Safer CRISPR? Cas13 version edits RNA, not DNA
Genetic Literacy Project
In a paper published in Science, researchers described an entirely new CRISPR-based gene editing tool that targets RNA, DNA’s sister, allowing for transient changes to genetic material. In Nature, scientists described how a more refined type of CRISPR …
Viewpoint: European anti-tech groups threaten to derail CRISPR gene editing in agricultureGrain Central (blog)

all 4 news articles »

Continue reading

2017-11-01 Michael Zand NEWS

With tweaks to gene therapy, Bluebird Bio makes progress in sickle cell – STAT

With tweaks to gene therapy, Bluebird Bio makes progress in sickle cellSTATThe new data show that Bluebird has been able to increase the number of gene-corrected cells taking hold in the bone marrow of sickle cell patients by improving the manufacturin… Continue reading

2017-11-01 Michael Zand NEWS

CAR T-Cell Therapy Is Making Untreatable Cancer Treatable – Daily Beast

Collaboration to Develop Gene Therapies Delivery
Labmate Online
A research collaboration is to assess the effectiveness of developing gene therapies using Avacta Group’s Affimer technology combined with FIT Biotech Oy’s gtGTU® platform. The very small, simply structured Affirmer proteins have ideal potential for …

Continue reading

2017-11-01 Michael Zand NEWS

CAR T-Cell Therapy Is Making Untreatable Cancer Treatable – Daily Beast

CAR T-Cell Therapy Is Making Untreatable Cancer Treatable
Daily Beast
Straddling this balance is chimeric antigen receptor (CAR) T-cell therapy: a revolutionary cancer treatment where doctors take a patient’s own T-cells (which play a significant role in the body’s cell-mediated immune response), genetically reengineer …
Mayo Clinic to Offer CAR T-Cell Therapy for Relapsed Non-Hodgkin LymphomaNewswise (press release)

all 2 news articles »

Continue reading

2017-11-01 Michael Zand NEWS

Editas Medicine, Inc. (NASDAQ:EDIT) Stock Traded Higher Than Its 50 Day Moving Average – Highlight Press

Editas Medicine, Inc. (NASDAQ:EDIT) Stock Traded Higher Than Its 50 Day Moving AverageHighlight PressCRISPR uses a protein-ribonucleic acid (RNA) complex composed of an enzyme, including either Cas9 (CRISPR associated protein 9) or Cpf1 (CRISPR from Pr… Continue reading

2017-11-01 Michael Zand NEWS

Editas Medicine, Inc. (NASDAQ:EDIT) Traded 7.6% Above Its 50 Day Moving Average – First News 24

Editas Medicine, Inc. (NASDAQ:EDIT) Traded 7.6% Above Its 50 Day Moving AverageFirst News 24CRISPR uses a protein-ribonucleic acid (RNA) complex composed of an enzyme, including either Cas9 (CRISPR associated protein 9) or Cpf1 (CRISPR from Prevotella … Continue reading

2017-11-01 Michael Zand NEWS

Gene Therapy Global Market 2017 Key Players,Share, Trend, Segmentation and Forecast to 2022 – Medgadget (blog)

Gene Therapy Global Market 2017 Key Players,Share, Trend, Segmentation and Forecast to 2022Medgadget (blog)This report contains a comprehensive listing of all gene therapy partnering deals announced since 2010 including financial terms where available … Continue reading

2017-11-01 Michael Zand NEWS
  • 1
  • …
  • 959
  • 960
  • 961
  • 962
  • 963
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

CAR T-Cell Therapy Is Making Untreatable Cancer Treatable
Daily Beast
Straddling this balance is chimeric antigen receptor (CAR) T-cell therapy: a revolutionary cancer treatment where doctors take a patient’s own T-cells (which play a significant role in the body’s cell-mediated immune response), genetically reengineer …
Mayo Clinic to Offer CAR T-Cell Therapy for Relapsed Non-Hodgkin LymphomaNewswise (press release)

all 2 news articles »